​​

DAY 2 - 1 May 2026

07:30 AM - 08:00 AM

Registration 

Speaker

08:00 AM - 09:30 AM

RENAL TRANSPLANTATION (1)

 

  • Kidney Transplantation in Qatar: Data, Directions, and Disparities

  • Biomarkers and Predictive Models in Kidney Transplantation

  • Antibody-Mediated Rejection: New Prospects and Potential Therapies

[Essa Abuhalaiqa (QAT)]

[Alexandre Loupy (France)]

[Lionel Couzi (FRA)]

09:30 AM - 10:00 AM

 Coffee Break

10:00 AM - 11:30 AM

RENAL TRANSPLANTATION (2)

 
  • Transplantation in the Highly Sensitized: Strategies for Success

  • The Evolving Role of Crossmatch Techniques

  • Immuno-Tolerance: New Era of Immunosuppression-Free Transplantation

[Lionel Couzi (FRA)]

[Dr Medhat Askar (Qat)]

[Alexandre Loupy (France)]

11:30 AM - 01:00 PM

Prayer and Lunch Break

01:00 PM - 03:00 PM

GLOMERULAR DISEASES & VASCULITIS (1)

 
  • Navigating New Treatment Horizons in IgA Nephropathy 

  • Thrombotic Microangiopathies: From Diagnosis to Individualized Management

  • Targeted Therapy in ANCA-Associated Vasculitis: What’s New and What Works

  • From PLA2R to Beyond: Uncovering New Antigens in Membranous Nephropathy 

[Jonathan Barratt (UK)] Virtual] 

[Anuja Java (USA)]


[David Jayne (UK)]

[Sanjeev Sethi (USA) Virtual] 

03:00 PM - 03:30 PM

Prayer & Coffee break

03:30 PM - 04:30 PM

GLOMERULAR DISEASES & VASCULITIS (2)

 
  • Personalized Management in Lupus Nephritis

[David Jayne (UK)]

 
  • Complement and Beyond: C3GN and ICGN in the Era of Precision Medicine

[Anuja Java (USA)]

04:30 PM - 06:00 PM

PARALLEL WORKSHOPS

  • Nephro-Pathology in Practice: Interactive Microscopy and Diagnostic Pearls
    [Turki Al-Hussain (KSA)]

  • PD Unleashed: Advanced Techniques and Troubleshooting– Hands-on Session 
    [Edwina Brown (UK)
 

06:00 PM - 06:30 PM

Prayer & Coffee Break

 

06:30 PM - 08:00 PM

PREGNANCY AND KIDNEY DISEASE

 
  • Hypertension and Preeclampsia: Risk Stratification, Management and Future Health

  • Pregnancy in Patients with Lupus Nephritis: Planning Across the Spectrum

  • Personalized Strategies for Safe Outcomes for all Kidney Disease Severities and Etiology

[Kate Bramham (UK)]

[Samar Al-Emadi (QAT)]

[Kate Bramham (UK)]